Vitamin D deficiency in Australian early-stage breast cancer patients starting aromatase inhibitors.
A randomized, double-blind, placebo-controlled trial for prevention of oxalipatin-induced peripheral neuropathy symptoms with pregabalin in patients with advanced colorectal cancer. Pilot study on ...
Please provide your email address to receive an email when new articles are posted on . Use of an aromatase inhibitor instead of tamoxifen reduced the risk for breast cancer recurrence among ...
An international team of scientists from Switzerland Spain, has studied the genetic basis of aromatase deficiency, a rare metabolic disorder that prevents the production of estrogens in humans, ...
Please provide your email address to receive an email when new articles are posted on . Bradley and colleagues performed a meta-analysis of data from four randomized trials — ABCSG 12, TEXT, SOFT and ...
Effect of pregnancy, in the year prior and after treatment for breast carcinoma, on survival and recurrence in women with breast cancer younger than 35 years. GETNA GROUP ...
Premenopausal women with ER-positive breast cancer experienced a decreased rate of recurrence when given an aromatase inhibitor, compared with those given tamoxifen. However, more research is still ...
An updated joint position statement on the management of aromatase inhibitor-associated bone loss (AIBL) addresses the heightened fracture risk in women undergoing endocrine therapy for ...
The latest studies on aromatase deficiency in humans come from the group of Amit V. Pandey and Christa E. Flück at the Department for BioMedical Research, University of Bern, and Pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback